$AMRN
AMARIN CORP PLC\UK

2015 Form 10-K Financial Statement

#000119312516476872 Filed on February 25, 2016

View on sec.gov

Income Statement

Concept 2015 2014 Q4 2014 Q3
Revenue $81.76M $16.48M $14.15M
YoY Change 50.84% 63.07% 68.38%
Cost Of Revenue $27.88M $5.800M $5.366M
YoY Change 36.08% 41.46% 45.74%
Gross Profit $53.88M $10.60M $8.783M
YoY Change 59.8% 76.67% 86.04%
Gross Profit Margin 65.9% 64.32% 62.08%
Selling, General & Admin $101.0M $18.40M $19.27M
YoY Change 27.34% -6.6% -31.85%
% of Gross Profit 187.53% 173.58% 219.4%
Research & Development $51.06M $12.40M $14.46M
YoY Change 1.46% -25.3% -14.05%
% of Gross Profit 94.77% 116.98% 164.6%
Depreciation & Amortization $200.0K $210.0K $210.0K
YoY Change 0.0% -8.7% -8.7%
% of Gross Profit 0.37% 1.98% 2.39%
Operating Expenses $152.1M $30.90M $33.73M
YoY Change 17.3% -14.88% -25.21%
Operating Profit -$98.22M -$20.30M -$24.94M
YoY Change 2.36% -33.0% -38.22%
Interest Expense $20.18M -$3.400M -$4.876M
YoY Change 8.64% -117.53% -42.23%
% of Operating Profit
Other Income/Expense, Net -$228.0K -$200.0K -$247.0K
YoY Change -106.12% -50.0% -18.21%
Pretax Income -$118.3M -$23.80M -$25.60M
YoY Change 99.81% 72.46% -49.32%
Income Tax -$3.086M -$4.100M $449.0K
% Of Pretax Income
Net Earnings -$115.2M -$19.66M -$26.05M
YoY Change 104.39% 27.55% -46.71%
Net Earnings / Revenue -140.91% -119.28% -184.11%
Basic Earnings Per Share -$0.83 -$0.11 -$0.15
Diluted Earnings Per Share -$0.83 -$0.11 -$0.17
COMMON SHARES
Basic Shares Outstanding 180.7M shares 174.5M shares
Diluted Shares Outstanding 180.7M shares 175.1M shares

Balance Sheet

Concept 2015 2014 Q4 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.0M $119.5M $135.4M
YoY Change -10.46% -37.6% -40.06%
Cash & Equivalents $107.0M $119.5M $135.4M
Short-Term Investments
Other Short-Term Assets $3.800M $2.633M $2.980M
YoY Change -7.32% 68.46% -15.75%
Inventory $19.00M $13.73M $11.89M
Prepaid Expenses
Receivables $13.80M $7.842M $6.667M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $143.5M $145.3M $158.0M
YoY Change -1.24% -33.78% -39.81%
LONG-TERM ASSETS
Property, Plant & Equipment $200.0K $381.0K $424.0K
YoY Change -50.0% -34.2% -34.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $20.00M $2.826M $4.823M
YoY Change 29.87% -35.18% -9.6%
Total Long-Term Assets $29.70M $25.83M $27.33M
YoY Change 15.12% -21.91% -12.63%
TOTAL ASSETS
Total Short-Term Assets $143.5M $145.3M $158.0M
Total Long-Term Assets $29.70M $25.83M $27.33M
Total Assets $173.2M $171.1M $185.4M
YoY Change 1.23% -32.23% -36.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.80M $8.525M $6.059M
YoY Change 27.06% 33.73% -2.79%
Accrued Expenses $19.90M $16.30M $15.40M
YoY Change 41.13% 69.79% 23.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $14.70M $15.39M $13.79M
YoY Change -4.55% 18.65% 26.51%
Total Short-Term Liabilities $50.70M $40.31M $35.34M
YoY Change 25.81% 7.37% 12.89%
LONG-TERM LIABILITIES
Long-Term Debt $236.4M $89.62M $89.15M
YoY Change 7.99% 2.17% 2.1%
Other Long-Term Liabilities $13.60M $386.0K $640.0K
YoY Change 3300.0% -41.34% -21.09%
Total Long-Term Liabilities $250.0M $90.00M $89.79M
YoY Change 14.0% 1.84% 1.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $50.70M $40.31M $35.34M
Total Long-Term Liabilities $250.0M $90.00M $89.79M
Total Liabilities $300.8M $259.6M $254.6M
YoY Change 15.87% -9.35% -18.27%
SHAREHOLDERS EQUITY
Retained Earnings -$970.2M -$950.6M
YoY Change 6.17% 5.8%
Common Stock $882.0M $881.6M
YoY Change 0.2% 0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost) $217.0K $217.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares 20.08K shares 20.08K shares
Shareholders Equity -$127.6M -$88.45M -$69.24M
YoY Change
Total Liabilities & Shareholders Equity $173.2M $171.1M $185.4M
YoY Change 1.23% -32.23% -36.91%

Cashflow Statement

Concept 2015 2014 Q4 2014 Q3
OPERATING ACTIVITIES
Net Income -$115.2M -$19.66M -$26.05M
YoY Change 104.39% 27.55% -46.71%
Depreciation, Depletion And Amortization $200.0K $210.0K $210.0K
YoY Change 0.0% -8.7% -8.7%
Cash From Operating Activities -$84.02M -$15.92M -$19.88M
YoY Change 12.61% -51.87% -55.66%
INVESTING ACTIVITIES
Capital Expenditures $28.00K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$30.00K $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $194.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 71.47M 20.00K 4.790M
YoY Change 2617.49% -101.55% -96.05%
NET CHANGE
Cash From Operating Activities -84.02M -15.92M -19.88M
Cash From Investing Activities -30.00K 0.000 0.000
Cash From Financing Activities 71.47M 20.00K 4.790M
Net Change In Cash -12.58M -15.90M -15.09M
YoY Change -82.52% -53.74% -119.74%
FREE CASH FLOW
Cash From Operating Activities -$84.02M -$15.92M -$19.88M
Capital Expenditures $28.00K $0.00 $0.00
Free Cash Flow -$84.05M -$15.92M -$19.88M
YoY Change 12.65% -51.87% -55.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Share Price
SharePrice
2.39
CY2015Q2 dei Entity Public Float
EntityPublicFloat
433300000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1243000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1674000
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2469000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-3997000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
260242000
CY2013Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
17994000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
15600000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
600000
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5225000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
934000
CY2014Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10215000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.95
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20079 shares
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
9400000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1700000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
88999000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-33856000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191514000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10670000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
174590372 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
174610451 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40306000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3525000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
588000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
89617000
CY2014Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
81000000
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
15394000
CY2014Q4 us-gaap Liabilities
Liabilities
259555000
CY2014Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
7519000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
143113000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
738890000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2487000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
386000
CY2014Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
7090000
CY2014Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
7400000
CY2014Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1509000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
85965000
CY2014Q4 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
12800000
CY2014Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1400000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-970234000
CY2014Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
121846000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-88448000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
171107000
CY2014Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
16387000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8525000
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2245000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2141000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3751000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
381000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
145281000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10063000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
969000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119539000
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4757000
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
217000
CY2014Q4 us-gaap Assets
Assets
171107000
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
12556000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
99455000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
1708000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
80096000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2633000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7842000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2826000
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
13490000
CY2014Q4 us-gaap Inventory Net
InventoryNet
13733000
CY2014Q4 amrn Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
-90000
CY2014Q4 amrn Research And Development Accrued Expense Current
ResearchAndDevelopmentAccruedExpenseCurrent
4391000
CY2014Q4 amrn Accrued Liabilities Sales Allowances Current
AccruedLiabilitiesSalesAllowancesCurrent
4717000
CY2014Q4 amrn Preferred Stock Equivalent Ordinary Shares Upon Future Conversion
PreferredStockEquivalentOrdinarySharesUponFutureConversion
0 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2756000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
10886523 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17818053 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8960000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.02
CY2015Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
0.1 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
183403263 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
9406000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
328184640 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.04
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.76
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
174502 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
183577765 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
328184640 shares
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50723000
CY2015Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
20600000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5241000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
754000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
91512000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
13308000
CY2015Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
87700000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
816171000
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
14742000
CY2015Q4 us-gaap Liabilities
Liabilities
302653000
CY2015Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
8170000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2207000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
149978000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1550000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
505000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
335000
CY2015Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
15796000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
923000
CY2015Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
8170000
CY2015Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3141000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1155000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
94684000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
24364000
CY2015Q4 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
11500000
CY2015Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1400000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
127000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1119293000
CY2015Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
138605000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-129191000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
173462000
CY2015Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
1368000
CY2015Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
24226000
CY2015Q4 us-gaap Purchase Obligation
PurchaseObligation
44700000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10832000
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
523000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4284000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3076000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8249000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
243000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
143524000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
17975000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1949000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
646000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
600000
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
9096000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
646000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
520000
CY2015Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
18270000
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11624000
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
14100000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9417000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106961000
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
833000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
646000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
646000
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1640000
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
411000
CY2015Q4 us-gaap Assets
Assets
173462000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
18233000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
112917000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
2796000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
6187000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
88996000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3152000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13826000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
997000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2045000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
18233000
CY2015Q4 us-gaap Inventory Net
InventoryNet
18985000
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
646000
CY2015Q4 amrn Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
74000
CY2015Q4 amrn Write Offs Of Accounts Receivables
WriteOffsOfAccountsReceivables
0
CY2015Q4 amrn Cash Discount Percent
CashDiscountPercent
0.02 pure
CY2015Q4 amrn Deferred Tax Liabilities Subject To Expiration
DeferredTaxLiabilitiesSubjectToExpiration
579000
CY2015Q4 amrn Operating Leases Future Minimum Payments Due In Four Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInFourYearsAndThereafter
0
CY2015Q4 amrn Research And Development Accrued Expense Current
ResearchAndDevelopmentAccruedExpenseCurrent
828000
CY2015Q4 amrn Deferred Tax Assets Operating Loss Carryforwards Change In Amount
DeferredTaxAssetsOperatingLossCarryforwardsChangeInAmount
52400000
CY2015Q4 amrn Accrued Liabilities Sales Allowances Current
AccruedLiabilitiesSalesAllowancesCurrent
10732000
CY2015Q4 amrn Preferred Stock Equivalent Ordinary Shares Upon Future Conversion
PreferredStockEquivalentOrdinarySharesUponFutureConversion
32818464 shares
CY2015Q4 amrn Private Placement Issuance Number Of Tranches
PrivatePlacementIssuanceNumberOfTranches
2 Tranche
CY2015Q4 amrn Deferred Tax Assets Tax Credit Carryforwards Resulting From Excess Tax Benefits Of Stockbased Compensation
DeferredTaxAssetsTaxCreditCarryforwardsResultingFromExcessTaxBenefitsOfStockbasedCompensation
3000000
CY2015Q1 amrn Private Placement Closing Date
PrivatePlacementClosingDate
2015-03-30
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.91 pure
CY2013 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
6048000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.10 pure
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161022000 shares
CY2013 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
33106000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-190336000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0091 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.18
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0207 pure
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
167070000 shares
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.28
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-166227000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14000
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
121206000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14685000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1189000
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
26351000
CY2013 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-47936000
CY2013 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
27000
CY2013 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
2008000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-182106000
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5429000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-169421000
CY2013 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
10000
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
26351000
CY2013 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-214163000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3645000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
687000
CY2013 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1000000
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
343000
CY2013 us-gaap Interest Paid
InterestPaid
6090000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
627000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-9234000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1690000
CY2013 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-591000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-166227000
CY2013 us-gaap Gross Profit
GrossProfit
14439000
CY2013 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
47710000
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
1395000
CY2013 us-gaap Interest Expense
InterestExpense
34179000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
121206000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1000000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
118000
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
246000
CY2013 us-gaap Operating Expenses
OperatingExpenses
196545000
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-33106000
CY2013 us-gaap Depreciation
Depreciation
200000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
121622000
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
646000
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-42355000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3194000
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4065000
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1708000
CY2013 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
256000
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
240000
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1703000
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
17631000
CY2013 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
14300000
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3434000
CY2013 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
125000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-68728000
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
10454000
CY2013 us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
361000
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
160000
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
33106000
CY2013 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
27000
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
122000
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
18494000
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
631000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
14685000
CY2013 us-gaap Restricted Stock Expense
RestrictedStockExpense
400000
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
123795000
CY2013 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-7228000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-14000
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
11912000
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
627000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
72750000
CY2013 amrn Income Tax Reconciliation Derivative Liabilities
IncomeTaxReconciliationDerivativeLiabilities
-11984000
CY2013 amrn Income Tax Rate Reconciliation Cumulative Translation Adjustment Amount
IncomeTaxRateReconciliationCumulativeTranslationAdjustmentAmount
-280000
CY2013 amrn Adjustments To Additional Paid In Capital Warrants Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantsExercised
24000
CY2013 amrn Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
160000
CY2013 amrn Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
24000
CY2013 amrn Increase Decrease In Lease Related Liabilities
IncreaseDecreaseInLeaseRelatedLiabilities
6000
CY2013 amrn Excess Tax Benefit Tax Deficiency From Share Based Compensation Operating Activities
ExcessTaxBenefitTaxDeficiencyFromShareBasedCompensationOperatingActivities
-361000
CY2013 amrn Excess Tax Benefit Tax Deficiency From Share Based Compensation Financing Activities
ExcessTaxBenefitTaxDeficiencyFromShareBasedCompensationFinancingActivities
-361000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.97 pure
CY2014 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
105000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.09 pure
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
173719000 shares
CY2014 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
-3034000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-72309000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0137 pure
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
234500 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.58
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0168 pure
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173824000 shares
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2014 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2480000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9022000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-56364000
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
38034000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3727000
CY2014 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1455000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-95955000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12958000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59201000
CY2014 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
36000
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
54202000
CY2014 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-63139000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4197000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1067000
CY2014 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-400000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
96000
CY2014 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-10100000
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
54202000
CY2014 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-6775000
CY2014 us-gaap Interest Paid
InterestPaid
10033000
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5081000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
307000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7331000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1053000
CY2014 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4014000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-56364000
CY2014 us-gaap Gross Profit
GrossProfit
33717000
CY2014 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
13472000
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
781000
CY2014 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
32460000
CY2014 us-gaap Interest Expense
InterestExpense
18575000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1000000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
117000
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
198000
CY2014 us-gaap Operating Expenses
OperatingExpenses
129672000
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
3335000
CY2014 us-gaap Depreciation
Depreciation
200000
CY2014 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
25431000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
334000
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
646000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14786000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2837000
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3689000
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1073000
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
254000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
777000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1703000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5863000
CY2014 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7700000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3614000
CY2014 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
10026000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-71975000
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2420000
CY2014 us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
2299000
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1651000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3034000
CY2014 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
660000
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
9493000
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-226000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
9022000
CY2014 us-gaap Restricted Stock Expense
RestrictedStockExpense
1400000
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
79346000
CY2014 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
8811000
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
20485000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
307000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50326000
CY2014 amrn Repurchase Of Conversion Options On Long Term Debt
RepurchaseOfConversionOptionsOnLongTermDebt
10100000
CY2014 amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
-128000
CY2014 amrn Income Tax Reconciliation Derivative Liabilities
IncomeTaxReconciliationDerivativeLiabilities
-2706000
CY2014 amrn Income Tax Rate Reconciliation Cumulative Translation Adjustment Amount
IncomeTaxRateReconciliationCumulativeTranslationAdjustmentAmount
8061000
CY2014 amrn Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Refund
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsRefund
3191000
CY2014 amrn Proceeds From Refund Of Stock Issuance Costs
ProceedsFromRefundOfStockIssuanceCosts
3191000
CY2014 amrn Valuation Allowances And Reserves Foreign Currency Translation
ValuationAllowancesAndReservesForeignCurrencyTranslation
-8115000
CY2014 amrn Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
1684888 shares
CY2014 amrn Income Tax Reconciliation Gain Loss On Extinguishment Of Debt
IncomeTaxReconciliationGainLossOnExtinguishmentOfDebt
-9509000
CY2014 amrn Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
1651000
CY2014 amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
2280000
CY2014 amrn Proceeds From Warrant Exercises Gross
ProceedsFromWarrantExercisesGross
1700000
CY2014 amrn Excess Tax Benefit Tax Deficiency From Share Based Compensation Operating Activities
ExcessTaxBenefitTaxDeficiencyFromShareBasedCompensationOperatingActivities
-2299000
CY2014 amrn Excess Tax Benefit Tax Deficiency From Share Based Compensation Financing Activities
ExcessTaxBenefitTaxDeficiencyFromShareBasedCompensationFinancingActivities
-2299000
CY2015 dei Document Type
DocumentType
10-K
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2015 dei Trading Symbol
TradingSymbol
AMRN
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0000897448
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.86 pure
CY2015 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
810000 shares
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.97 pure
CY2015 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18px;margin-bottom:0px; margin-left:2%"> <font style="font-family:Times New Roman" size="2"><b><i><u>Concentration of Credit Risk</u></i></b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains substantially all of its cash and cash equivalents in financial institutions believed to be of high-credit quality.</font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2">A significant portion of the Company&#x2019;s sales are to wholesalers in the pharmaceutical industry. The Company monitors the creditworthiness of customers to whom it grants credit terms and has not experienced any credit losses. The Company does not require collateral or any other security to support credit sales. The Company&#x2019;s top three customers accounted for 95% of gross product sales for each of the years ending December&#xA0;31, 2015 and 2014, and represented 95% and 96% of the gross accounts receivable balance as of December&#xA0;31, 2015 and 2014, respectively. The Company has not experienced any write-offs of its accounts receivable.</font></p> </div>
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.16
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180654000 shares
CY2015 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P14Y7M6D
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18020 shares
CY2015 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
8719000
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.75
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.76
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-84748000
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0137 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.16
CY2015 dei Entity Registrant Name
EntityRegistrantName
AMARIN CORP PLC\UK
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18px;margin-bottom:0px; margin-left:2%"> <font style="font-family:Times New Roman" size="2"><b><i><u>Use of Estimates</u></i></b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2">Accounting estimates are based on historical experience and other factors that are considered reasonable under the circumstances. Estimates are used in determining such items as provisions for sales returns, rebates and incentives, chargebacks, and other sales allowances; depreciable/amortizable lives; asset impairments; valuation allowance on deferred taxes; probabilities of achievement of performance conditions for certain equity awards; amounts recorded for licensing revenue; contingencies and accruals; and valuations of derivative and long-term debt instruments. Because of the uncertainties inherent in such estimates, actual results may differ from these estimates. Management periodically evaluates estimates used in the preparation of the consolidated financial statements for continued reasonableness.</font></p> </div>
CY2015 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0168 pure
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180654000 shares
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7976000 shares
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y10M24D
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-149059000
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1314000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28000
CY2015 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
109000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13872000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-228000
CY2015 us-gaap Licenses Revenue
LicensesRevenue
769000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1284000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-98222000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5252000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-118290000
CY2015 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
5000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
81756000
CY2015 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-149059000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5984000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
144000
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
132000
CY2015 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-1300000
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
80987000
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-187000
CY2015 us-gaap Interest Paid
InterestPaid
12559000
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
16291000
CY2015 us-gaap Gross Profit
GrossProfit
53881000
CY2015 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1106000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10137000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
120000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
519000
CY2015 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-431000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-115204000
CY2015 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
16145000
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
194000
CY2015 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
727000
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
711000
CY2015 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
56229000
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-194000
CY2015 us-gaap Interest Expense
InterestExpense
20180000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
113000
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
166000
CY2015 us-gaap Operating Expenses
OperatingExpenses
152103000
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-9023000
CY2015 us-gaap Depreciation
Depreciation
200000
CY2015 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
40626000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
72198000
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
646000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-29572000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3086000
CY2015 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
57666000
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3343000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
561000
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
439000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1166000
CY2015 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-1300000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
14231000
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
762000
CY2015 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
52800000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6000
CY2015 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
27514000
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8258000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8719000
CY2015 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7900000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4252000
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2015 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
4804000
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1053000
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
8572000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-605000
CY2015 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
868000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
13889000
CY2015 us-gaap Restricted Stock Expense
RestrictedStockExpense
6000000
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
101041000
CY2015 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
10489000
CY2015 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
2248000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12578000
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-652000
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2713000
CY2015 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
32987000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-28000
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
27875000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51062000
CY2015 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-51000
CY2015 amrn Repurchase Of Conversion Options On Long Term Debt
RepurchaseOfConversionOptionsOnLongTermDebt
1300000
CY2015 amrn Cash Discount Invoice Terms
CashDiscountInvoiceTerms
P30D
CY2015 amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
-449000
CY2015 amrn Income Tax Reconciliation Derivative Liabilities
IncomeTaxReconciliationDerivativeLiabilities
187000
CY2015 amrn Income Tax Rate Reconciliation Cumulative Translation Adjustment Amount
IncomeTaxRateReconciliationCumulativeTranslationAdjustmentAmount
7811000
CY2015 amrn Derivative Liabilities Transferred To Stockholders Equity
DerivativeLiabilitiesTransferredToStockholdersEquity
1814000
CY2015 amrn Valuation Allowances And Reserves Foreign Currency Translation
ValuationAllowancesAndReservesForeignCurrencyTranslation
-7572000
CY2015 amrn Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
1844585 shares
CY2015 amrn Equity Offering Costs
EquityOfferingCosts
700000
CY2015 amrn Accounts Receivable Credit Period
AccountsReceivableCreditPeriod
P30D
CY2015 amrn Income Tax Reconciliation Gain Loss On Extinguishment Of Debt
IncomeTaxReconciliationGainLossOnExtinguishmentOfDebt
-328000
CY2015 amrn Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
2713000
CY2015 amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
6448000
CY2015 amrn Proceeds From Warrant Exercises Gross
ProceedsFromWarrantExercisesGross
2800000
CY2015 amrn Derivative Liabilities Transferred To Equity Classifications
DerivativeLiabilitiesTransferredToEquityClassifications
868000
CY2015 amrn Excess Tax Benefit Tax Deficiency From Share Based Compensation Operating Activities
ExcessTaxBenefitTaxDeficiencyFromShareBasedCompensationOperatingActivities
727000
CY2015 amrn Excess Tax Benefit Tax Deficiency From Share Based Compensation Financing Activities
ExcessTaxBenefitTaxDeficiencyFromShareBasedCompensationFinancingActivities
727000
CY2015 amrn Preferred Stock Purchase Option
PreferredStockPurchaseOption
946000
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
10967000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-25980000
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
15933000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-31994000
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
12606000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
15323000
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
17707000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-62853000
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
14149000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-26050000
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
21483000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-32321000
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
16480000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-19657000
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
26633000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-21891000

Files In Submission

Name View Source Status
0001193125-16-476872-index-headers.html Edgar Link pending
0001193125-16-476872-index.html Edgar Link pending
0001193125-16-476872.txt Edgar Link pending
0001193125-16-476872-xbrl.zip Edgar Link pending
amrn-20151231.xml Edgar Link completed
amrn-20151231.xsd Edgar Link pending
amrn-20151231_cal.xml Edgar Link unprocessable
amrn-20151231_def.xml Edgar Link unprocessable
amrn-20151231_lab.xml Edgar Link unprocessable
amrn-20151231_pre.xml Edgar Link unprocessable
d113204d10k.htm Edgar Link pending
d113204dex211.htm Edgar Link pending
d113204dex231.htm Edgar Link pending
d113204dex232.htm Edgar Link pending
d113204dex311.htm Edgar Link pending
d113204dex312.htm Edgar Link pending
d113204dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g113204g54b24.jpg Edgar Link pending
g113204g62a32.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending